Figure 2.
Licensing factors that activate the HIF-1α pathway in MSCs lead to increased glycolysis and allow for the immunomodulatory actions carried out by MSCs. Created with BioRender.com.
Licensing factors that activate the HIF-1α pathway in MSCs lead to increased glycolysis and allow for the immunomodulatory actions carried out by MSCs. Created with BioRender.com.